Bio-pharmaceutical industry, the money voted for King winds up substantial new wealth Express
The future direction of development of biopharmaceuticals will be extended to agriculture, energy, etc., no wonder the wind will be a soft spot for.
“In the past, China’s university graduates biomedical professionals can not find a job, but now investors focused biomedical perspective, there are following the new round of Internet opportunities to create wealth.” On the 26th, Kai-Peng Founding Venture TDF partner to our reporter, said Zhong. Just one week ago, Kai Peng TDF to China’s largest outsourcing companies, one of biomedicine Kim Stewart Technology (Nanjing) Co., Ltd. signed a 15 million U.S. dollars investment risk. This is Peng Kai TDF medicine in China this year [13.69 0.22%] [13.69 0.22%] of the first areas of investment.
Countries in the next few days “to promote the biotechnology industry to accelerate the development of a number of policy” After, “will have more money to venture capital organizations tend to invest in bio-technology enterprises.” Ways investors are swarming into the bio-pharmaceutical industry.
Translate (most links are in Chinese)